Office of the Inspector General
OIG Report Finds Indian Health Services Did Not Ensure Appropriate Use of COVID-19 Testing Funds
The audit found that five programs under the Indian Health Service spent $480,437 on expenses that didn't support COVID-19 testing or testing-related activities.
HHS OIG Finds CMS Oversight Failed to Reduce Risk of Improper Genetic Testing Payments
The agency's audit was intended to determine whether CMS oversight of payments for rare disease testing code 81408 was adequate in reducing the risk of inappropriate payments.
HHS OIG Report Finds Medicare Spending on Lab Tests Increased 17 Percent in 2021
Spending increased to $9.3 billion in 2021, up from $8.0 billion in 2020 and the biggest change in spending since OIG began monitoring payments in 2014.
FDA Allowed Problematic COVID-19 Tests on the Market Due to Agency's EUA Approach, HHS OIG Finds
In a report released on Wednesday, the office critiqued the FDA's pandemic performance and recommended new approaches.
HHS OIG Report Finds Lab Spending Increased in 2018 Despite PAMA Rate Reductions
The report noted that savings from the lower payment rates were offset by increased spending on other tests, including genetic tests.